Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement

By Adam Lidgett · April 11, 2025, 7:27 PM EDT

Kidney-focused biotech Aurinia Pharmaceuticals Inc. on Friday launched a lawsuit in New Jersey federal court claiming that Lotus Pharmaceutical Co. Ltd.'s bid to sell a generic form of Aurinia's lupus nephritis...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

AURINIA PHARMACEUTICALS INC. v. LOTUS PHARMACEUTICAL CO., LTD.

Case Number

2:25-cv-02613

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

April 11, 2025